In a recent study on a cohort of 32 patients with head and neck cancer treated with chemoradiotherapy IL-1β and TNF-α levels decreased 60 days after treatment as compared to the pre-treatment level whereas IL-6 levels increased (25). Here, IL6 is linked to head and neck cancer.